Levalbuterol is not more cost-effective than albuterol for COPD.
Hendeles
Leslie
L
Hartzema
Abraham
A
D000420:Albuterol / Q000191:economics* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000191:economics*; D015982:Bias; D001993:Bronchodilator Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis / Q000706:statistics & numerical data; D006760:Hospitalization / Q000191:economics; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy / Q000191:economics*
D001993:Bronchodilator Agents; D000420:Albuterol